Skip to main content
Erschienen in: Journal of Neurology 9/2012

01.09.2012 | Original Communication

Substance abuse may be a risk factor for earlier onset of Huntington disease

verfasst von: Joanne A. Byars, Leigh J. Beglinger, David J. Moser, Pedro Gonzalez-Alegre, Peg Nopoulos

Erschienen in: Journal of Neurology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Environmental factors may contribute as much as one-third of the variance in Huntington disease (HD) age of onset. Substance abuse is a risk factor for other neurodegenerative disorders; however, whether substance abuse influences HD age of onset is not well established. This study investigated the relationships between alcohol, drug, and tobacco abuse and HD age of onset in 136 participants with symptomatic HD. CAG repeat length was used as a covariate in all analyses, as it represents the most significant determinant of HD age of onset. The relationship between substance abuse, HD age of onset, and sex was also examined, as women may experience greater medical harm from substance abuse. Lifetime alcohol abuse and lifetime drug abuse were associated with earlier age of HD onset; a similar trend was seen for current tobacco abuse. For women, lifetime alcohol abuse was associated with earlier onset of HD, with a similar trend for lifetime drug abuse. However, alcohol, drug, and tobacco abuse were not significantly associated with age of onset in men. Further work is needed to determine whether substance abuse is a causative risk factor for earlier onset of HD, and why the environmental factors associated with age of onset vary by sex.
Literatur
1.
Zurück zum Zitat Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503PubMedCrossRef Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci USA 101:3498–3503PubMedCrossRef
2.
Zurück zum Zitat Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504–513PubMedCrossRef Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61:504–513PubMedCrossRef
3.
Zurück zum Zitat Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007) Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69:998–1005PubMedCrossRef Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007) Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69:998–1005PubMedCrossRef
4.
Zurück zum Zitat Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C et al (2009) The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry 25:511–518CrossRef Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C et al (2009) The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry 25:511–518CrossRef
5.
Zurück zum Zitat Sabia S, Marmot M, Dufouil C, Singh-Manoux A (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165–1173PubMedCrossRef Sabia S, Marmot M, Dufouil C, Singh-Manoux A (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165–1173PubMedCrossRef
6.
Zurück zum Zitat Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F et al (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878–884PubMedCrossRef Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F et al (2010) Smoking duration, intensity, and risk of Parkinson disease. Neurology 74:878–884PubMedCrossRef
7.
Zurück zum Zitat Thomas VS, Rockwood KJ (2001) Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49:415–420PubMedCrossRef Thomas VS, Rockwood KJ (2001) Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49:415–420PubMedCrossRef
8.
Zurück zum Zitat Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann NY Acad Sci 1141:1–21PubMedCrossRef Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann NY Acad Sci 1141:1–21PubMedCrossRef
9.
Zurück zum Zitat Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA (1987) Which factors influence age at onset and rate of progression in Huntington’s disease? J Neurol Sci 80:299–306PubMedCrossRef Buruma OJ, Van der Kamp W, Barendswaard EC, Roos RA, Kromhout D, Van der Velde EA (1987) Which factors influence age at onset and rate of progression in Huntington’s disease? J Neurol Sci 80:299–306PubMedCrossRef
10.
Zurück zum Zitat Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK et al (1991) Factors associated with slow progression in Huntington’s disease. Arch Neurol 48:800–804PubMedCrossRef Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK et al (1991) Factors associated with slow progression in Huntington’s disease. Arch Neurol 48:800–804PubMedCrossRef
11.
Zurück zum Zitat Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA (2007) Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug Alcohol Depend 86:283–286PubMedCrossRef Ehret JC, Day PS, Wiegand R, Wojcieszek J, Chambers RA (2007) Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families. Drug Alcohol Depend 86:283–286PubMedCrossRef
12.
Zurück zum Zitat Friedman JH, Trieschmann ME, Myers RH, Fernandez HH (2005) Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 62:995–997PubMedCrossRef Friedman JH, Trieschmann ME, Myers RH, Fernandez HH (2005) Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol 62:995–997PubMedCrossRef
13.
Zurück zum Zitat Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78–87PubMedCrossRef Palmer RH, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78–87PubMedCrossRef
14.
Zurück zum Zitat Zilberman M, Tavares H (2003) el-Guebaly N. Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis 22:61–74PubMedCrossRef Zilberman M, Tavares H (2003) el-Guebaly N. Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J Addict Dis 22:61–74PubMedCrossRef
15.
Zurück zum Zitat Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265–272PubMedCrossRef Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265–272PubMedCrossRef
16.
17.
Zurück zum Zitat Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198–204PubMedCrossRef Hommer D, Momenan R, Kaiser E, Rawlings R (2001) Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158:198–204PubMedCrossRef
18.
Zurück zum Zitat Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896–901PubMedCrossRef Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 29:896–901PubMedCrossRef
19.
Zurück zum Zitat Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C et al (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363–1367PubMedCrossRef Paul CA, Au R, Fredman L, Massaro JM, Seshadri S, Decarli C et al (2008) Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 65:1363–1367PubMedCrossRef
20.
Zurück zum Zitat Mucha L, Stephenson J, Morandi N, Dirani R (2006) Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3:279–291PubMedCrossRef Mucha L, Stephenson J, Morandi N, Dirani R (2006) Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3:279–291PubMedCrossRef
21.
Zurück zum Zitat van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706–719PubMedCrossRef van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706–719PubMedCrossRef
22.
Zurück zum Zitat Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M et al (2007) Survival of Huntington’s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523–526PubMedCrossRef Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M et al (2007) Survival of Huntington’s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523–526PubMedCrossRef
23.
Zurück zum Zitat Foroud T, Gray J, Ivashina J, Conneally PM (1999) Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52–56PubMedCrossRef Foroud T, Gray J, Ivashina J, Conneally PM (1999) Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52–56PubMedCrossRef
24.
Zurück zum Zitat Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32 + neurons in males. Hum Mol Genet 17:2595–2609PubMedCrossRef Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32 + neurons in males. Hum Mol Genet 17:2595–2609PubMedCrossRef
25.
Zurück zum Zitat Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington’s disease. Behav Brain Res 178:90–97PubMedCrossRef Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington’s disease. Behav Brain Res 178:90–97PubMedCrossRef
26.
Zurück zum Zitat Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830–842PubMedCrossRef Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:830–842PubMedCrossRef
27.
Zurück zum Zitat Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566–576PubMedCrossRef Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566–576PubMedCrossRef
28.
Zurück zum Zitat Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol 81:294–330PubMedCrossRef Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol 81:294–330PubMedCrossRef
29.
Zurück zum Zitat Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36–57PubMedCrossRef Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36–57PubMedCrossRef
30.
Zurück zum Zitat Yeom M, Shim I, Lee HJ, Hahm DH (2005) Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326:321–328PubMedCrossRef Yeom M, Shim I, Lee HJ, Hahm DH (2005) Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326:321–328PubMedCrossRef
31.
Zurück zum Zitat Kenny PJ, File SE, Rattray M (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234–238PubMedCrossRef Kenny PJ, File SE, Rattray M (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234–238PubMedCrossRef
32.
Zurück zum Zitat Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82PubMedCrossRef Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82PubMedCrossRef
33.
Zurück zum Zitat Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15:89–100PubMedCrossRef Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15:89–100PubMedCrossRef
34.
35.
Zurück zum Zitat Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107–1115PubMedCrossRef Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107–1115PubMedCrossRef
Metadaten
Titel
Substance abuse may be a risk factor for earlier onset of Huntington disease
verfasst von
Joanne A. Byars
Leigh J. Beglinger
David J. Moser
Pedro Gonzalez-Alegre
Peg Nopoulos
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6415-8

Weitere Artikel der Ausgabe 9/2012

Journal of Neurology 9/2012 Zur Ausgabe

Medical Progress in the Journal of Neurology

Rehabilitation interventions in multiple sclerosis: an overview

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.